However, as AARS1 plays a fundamental role in tRNA aminoacylation and protein synthesis and its deficiency has been reported to be associated with neurological disorders and acute liver failure (46, 47), therapeutic targeting of AARS1 to treat GC warrants further investigations. The gene discussed is AARS1; the disease is nervous system disorder.